Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy
ClinicalTrials.gov study NCT01501370. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06163898. IPD Sharing: YES. Countries: 2. Publications: 0.
Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis
ClinicalTrials.gov study NCT03315026. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06644443. IPD Sharing: NO. Countries: 1. Publications: 0.
Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06484829. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT00652041. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of JNJ-64407564 in Japanese Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04773522. IPD Sharing: YES. Countries: 1. Publications: 0.
Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD
ClinicalTrials.gov study NCT05530096. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients with Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03399539. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
ClinicalTrials.gov study NCT04634435. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma
ClinicalTrials.gov study NCT00083577. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy
ClinicalTrials.gov study NCT02334865. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
ClinicalTrials.gov study NCT01861340. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST)
ClinicalTrials.gov study NCT07045909. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma
ClinicalTrials.gov study NCT01039025. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01199718. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00744354. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT)
ClinicalTrials.gov study NCT00311337. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01359657. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01266811. IPD Sharing: Not stated. Countries: 14. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.